HER2, chromosome 17 polysomy and DNA ploidy status in breast cancer; a translational study

Breast cancer treatment depends on human epidermal growth factor receptor-2 (HER2) status, which is often determined using dual probe fluorescence in situ hybridisation (FISH). Hereby, also loss and gain of the centromere of chromosome 17 (CEP17) can be observed (HER2 is located on chromosome 17). C...

Descripción completa

Detalles Bibliográficos
Autores principales: Halilovic, Altuna, Verweij, Dagmar I., Simons, Annet, Stevens-Kroef, Marian J. P. L., Vermeulen, Susan, Elsink, Janet, Tops, Bastiaan B. J., Otte-Höller, Irene, van der Laak, Jeroen A. W. M., van de Water, Carlijn, Boelens, Oliver B. A., Schlooz-Vries, Margrethe S., Dijkstra, Jeroen R., Nagtegaal, Iris D., Tol, Jolien, van Cleef, Patricia H. J., Span, Paul N., Bult, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690925/
https://www.ncbi.nlm.nih.gov/pubmed/31406196
http://dx.doi.org/10.1038/s41598-019-48212-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690925/
https://www.ncbi.nlm.nih.gov/pubmed/31406196
http://dx.doi.org/10.1038/s41598-019-48212-2

Ejemplares similares